Literature DB >> 23338248

[MRI for arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C)].

P Hunold1.   

Abstract

Arrhythmogenic right ventricular dysplasia/cardiomyopathy is a congenital disease that may present with sudden cardiac death as the first manifestation. Standards for the difficult clinical diagnosis are the so-called modified Task Force criteria that incorporate imaging-based, electrocardiographic and anamnestic information. Cardiac magnetic resonance imaging (MRI) is the standard technique for imaging of the right ventricle and can compliment the recent ARVD/C diagnosis criteria by providing exact information on right ventricular size and function. It is the most reliable modality available for the detection of right ventricular aneurysms and the quantification of ventricular size. Furthermore, MRI is able to identify areas of fatty or fibrous replacement within the right ventricular myocardium in a non-invasive way. However, a suspicion of ARVD/C cannot be confirmed or excluded based on MRI findings alone. In clinical routine cardiac MRI is an enormously important component in the ARVD/C diagnostic toolbox; however, MRI can only act as one part of the diagnostic puzzle and should exclusively be performed by experienced centers using specifically tailored protocols.

Entities:  

Mesh:

Year:  2013        PMID: 23338248     DOI: 10.1007/s00117-012-2383-3

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  26 in total

1.  Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.

Authors:  Barry J Maron; Paul D Thompson; Michael J Ackerman; Gary Balady; Stuart Berger; David Cohen; Robert Dimeff; Pamela S Douglas; David W Glover; Adolph M Hutter; Michael D Krauss; Martin S Maron; Matthew J Mitten; William O Roberts; James C Puffer
Journal:  Circulation       Date:  2007-03-12       Impact factor: 29.690

2.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

3.  Arrhythmogenic right ventricular dysplasia: MR features.

Authors:  M Midiri; M Finazzo; M Brancato; E Hoffmann; G Indovina; M D Maria; R Lagalla
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

4.  Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging.

Authors:  Harikrishna Tandri; Manoj Saranathan; E Rene Rodriguez; Claudia Martinez; Chandra Bomma; Khurram Nasir; Boas Rosen; João A C Lima; Hugh Calkins; David A Bluemke
Journal:  J Am Coll Cardiol       Date:  2005-01-04       Impact factor: 24.094

5.  Usefulness of magnetic resonance imaging for the diagnosis of right ventricular dysplasia in children.

Authors:  Mark A Fogel; Paul M Weinberg; Matthew Harris; Larry Rhodes
Journal:  Am J Cardiol       Date:  2006-03-06       Impact factor: 2.778

6.  Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy.

Authors:  Mark Norman; Michael Simpson; Jens Mogensen; Anthony Shaw; Sîan Hughes; Petros Syrris; Srijita Sen-Chowdhry; Edward Rowland; Andrew Crosby; William J McKenna
Journal:  Circulation       Date:  2005-08-02       Impact factor: 29.690

7.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.

Authors:  W J McKenna; G Thiene; A Nava; F Fontaliran; C Blomstrom-Lundqvist; G Fontaine; F Camerini
Journal:  Br Heart J       Date:  1994-03

Review 8.  MRI assessment of right ventricular dysplasia.

Authors:  Ernesto di Cesare
Journal:  Eur Radiol       Date:  2002-12-19       Impact factor: 5.315

9.  Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Chandra Bomma; Julie Rutberg; Harikrishna Tandri; Khurram Nasir; Ariel Roguin; Crystal Tichnell; Rene Rodriguez; Cynthia James; Edward Kasper; Philip Spevak; David A Bluemke; Hugh Calkins
Journal:  J Cardiovasc Electrophysiol       Date:  2004-03

Review 10.  Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies.

Authors:  Chirine Parsai; Rory O'Hanlon; Sanjay K Prasad; Raad H Mohiaddin
Journal:  J Cardiovasc Magn Reson       Date:  2012-08-02       Impact factor: 5.364

View more
  1 in total

1.  Single-Breath-Hold Evaluation of Cardiac Function with Use of Time-Resolved Parallel Cardiac Magnetic Resonance.

Authors:  Patrick Krumm; Jonas D Keuler; Stefanie Mangold; Tanja Zitzelsberger; Christer A Ruff; Bernhard D Klumpp; Petros Martirosian; Konstantin Nikolaou; Christof Burgstahler; Ulrich Kramer
Journal:  Tex Heart Inst J       Date:  2017-08-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.